Novel anti-inflammatory effects of canagliflozin involving Hexokinase II in lipopolysaccharide-stimulated human coronary artery endothelial cells - Uthman, Laween; Kuschma, Marius Christian; Römer, Gregor; Boomsma, Marleen; Keßler, Jens; Hermanides, Jeroen; Hollmann, Markus W.; Preckel, Benedikt; Zuurbier, Coert J.; Weber, Nina C. (Cardiovascular drugs and therapy, 2021)
"Published online: 13 October 2020".- S. 1083